Catalyst to Moderate a Panel at the American Society of Gene & Cell Therapy Policy Summit
Catalyst Founder and President, Nancy Myers, will be moderating a [...]
What Does the Future Hold for Medicaid, and How Will COVID-19 Impact the Public Payor Space in the Near Term
On June 16th at the Mostly Medicaid 2020 Summer Virtual [...]
Catalyst to Speak on COVID-19 Lessons Learned for Engaging FDA
Catalyst Healthcare Consulting will be speaking at an Informa Pharma [...]
Gene Therapy CMC Constriction Points and Ideas for Solutions – A Catalyst Moderated Panel at the DIA 2020 Annual Meeting
On June 15th at the DIA (Virtual) Annual Meeting, Catalyst’s [...]
Hahn Pledges FDA Independence While Maintaining Role On Warp Speed
In the Pink Sheet, Catalyst's Nancy Myers discusses the Administration's [...]
Woodcock, Marks Recusals From COVID-19 Product Reviews ‘Protect FDA’s Reputation’
In the Pink Sheet, Catalyst’s Nancy Myers commends how "Marks [...]
Health Insurers Hail SCOTUS Ruling in Risk Corridors Case
AIS Health Catalyst’s Jeff Myers weighs in on the SCOTUS [...]
Trump’s New Vaccine Timeline Met with Deep Skepticism
In The Hill, Catalyst’s Jeff Myers says the administration’s vaccine [...]
Race for Coronavirus Vaccine Faces Early Challenges
In The Hill, Catalyst’s Jeff Myers argues it’s unlikely early [...]
Medicaid MCOs Brace for COVID-Related Enrollment Surge
AIS Health – April 16, 2020 issue of RADAR on [...]